Results 41 to 50 of about 33,432 (282)

Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes

BMC Pharmacology and Toxicology, 2021
Background Dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia.
Mohammed Ahmed Fouad Shalaby, Hekma A. Abd El Latif, Mohamed El Yamani, May Ahmed Galal, Sherifa Kamal, Ikhlas Sindi, Raneem Masaood   +6 more
doaj   +1 more source

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction

Clinical Research in Cardiology, 2018
BackgroundRight ventricular (RV) dysfunction predicts adverse outcome in peripartum cardiomyopathy (PPCM). We recently demonstrated beneficial effects associated with the prolactin release inhibitor bromocriptine at different doses when added to standard
A. Haghikia, J. Schwab, J. Vogel-Claussen, D. Berliner, T. Pfeffer, T. König, C. Zwadlo, V. Moulig, A. Franke, Marziel Schwarzkopf, P. Ehlermann, R. Pfister, G. Michels, R. Westenfeld, V. Stangl, U. Kühl, E. Podewski, I. Kindermann, M. Böhm, K. Sliwa, D. Hilfiker-Kleiner, J. Bauersachs   +21 more
semanticscholar   +1 more source

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2

Ожирение и метаболизм, 2011
Bromocriptine is a sympatholytic agonist of dopamine receptors, which is now proposed for treatment of type 2 diabetes mellitus. In animal studies bromocriptine elevates the decreased levels of dopamine in hypothalamus and blocks excessive sympathetic ...
O. A. Gerasimenko, E. A. Pigarova, L. K. Dzeranova   +2 more
doaj   +1 more source

Bromocriptine for the Treatment of Peripartum Cardiomyopathy.

Cardiac failure review, 2018
Peripartum cardiomyopathy (PPCM) is a life-threatening, pregnancy-associated heart disease that develops towards the end of pregnancy or in the first months following delivery in previously healthy women.
T. Koenig, J. Bauersachs, D. Hilfiker-Kleiner   +2 more
semanticscholar   +1 more source

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control

Journal of Pharmacy and Bioallied Sciences, 2010
Food and Drug Administration (FDA) approved bromocriptine mesylate, a quick release formulation, 0.8 mg tablets, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Yogendra Keche
doaj   +1 more source

Severe Hypoglycemia Due To the Administration of Bromocriptine in a Non-Diabetic Patient: A Case Study

Case Reports in Clinical Practice, 2020
The patient was a 24-year-old man with persistent vegetative state following severe traumatic brain injury due to a car accident, who was referred to the emergency department with a generalized tonic-clonic seizure due to severe hypoglycemia. The patient
Saeed Choobkar, Samad Nazarpoor, Mojgan kaviani   +2 more
doaj   +1 more source

Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer

Molecular Cancer Therapeutics, 2018
Docetaxel resistance remains a major obstacle in the treatment of prostate cancer bone metastasis. In this study, we demonstrate that the dopamine D2 receptor (DRD2) agonist bromocriptine effectively enhances docetaxel efficacy and suppresses skeletal ...
Yang Yang, K. Mamouni, Xin Li, Yanhua Chen, S. Kavuri, Yuhong Du, H. Fu, O. Kucuk, Daqing Wu   +8 more
semanticscholar   +1 more source

Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering [PDF]

, 2020
OBJECTIVE: The authors have sought to expound upon and shed a light on the rise of nootropics, which have gradually taken on a more and more relevant role in workplaces and academic settings.
Bersani, G, Ciallella, C, Del Rio, A, Marinelli, E, Rinaldi, Raffaella, Zaami, S   +5 more
core   +1 more source

Prolactin [PDF]

, 1977
During an oral glucose tolerance test (OGTT) glucose and insulin levels were measured in 26 patients with prolactin-producing pituitary tumours without growth hormone excess.
A. Renauld, A. Weissmann, A.C. Herrington, A.J. Lostroh, B. Winkler, C.N. Hales, E. Cerasi, E.E. McGarry, F.H. Schmidt, I.B. Rathgeb, J. Tourniaire, J.D. Manns, K. von Werder, K. Werder von, K. Werder von, M. M. C. Landgraf-Leurs, M.O. Thorner, M.W. Sinkoff, P. Berle, P. C. Scriba, R. Hörl, R. Landgraf, R. Landgraf, R.C. Bodo De, Y.N. Sinha   +24 more
core   +1 more source

Central Hyperthermia Treated with Bromocriptine

Case Reports in Neurological Medicine, 2017
Introduction. Central hyperthermia is common in patients with brain injury. It typically has a rapid onset with high temperatures and marked fluctuations and responds poorly to antibiotics and antipyretics.
Prashant Natteru, Pravin George, Robert J. Bell, Premkumar Nattanmai, C. Newey   +4 more
semanticscholar   +1 more source